Daniel Joyce, MD

Daniel Joyce, MD, is an Assistant Professor in the Department of Urology at Vanderbilt University Medical Center, specializing in the treatment of kidney Cancer, testis Cancer, bladder Cancer, and prostate cancer.

Articles by Daniel Joyce, MD

Patient Selection, Counseling, and Improved Biomarkers, Imaging: Moving Forward From KEYNOTE-564

Sarah Psutka, MD, MScRenal Cell Carcinoma Diagnostics | May 7, 2024

Drs. Joyce and Psutka consider patient counseling for adjuvant RCC therapy, and biomarkers and imaging before treatment.

Automated Renal Volume Measurement Using AI: Postoperative Renal Function

Abhinav Khanna, MD, MPHRenal Cell Carcinoma Diagnostics | May 14, 2024

Drs. Joyce and Khanna examine the utility of a deep learning algorithm for automated renal volume calculation.

Active Surveillance Versus Intervention for Small Renal Masses: Imaging Modalities and Capabilities

Phillip Pierorazio, MDRenal Cell Carcinoma Diagnostics | May 14, 2024

Drs. Joyce and Pierorazio weigh appropriate surveillance versus primary intervention for clinical T1a kidney tumors.

Academic Solutions to Cost Containment, Financial Toxicity

Christopher Wallis, MD, PhD, FRCSCSUO 2023 | December 18, 2023

Drs. Joyce and Wallis consider the impact of financial toxicity and containing costs for patients with GU malignancies.